U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Fallopian Tube Endometrioid Adenocarcinoma

MedGen UID:
1708557
•Concept ID:
C5237037
•
Neoplastic Process

Definition

The reemergence of fallopian tube endometrioid adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Fallopian Tube Endometrioid Adenocarcinoma

Professional guidelines

PubMed

Risk-stratifying clinicopathologic criteria for ovarian preservation in premenopausal women with early stage low-risk endometrial cancer.
Khadraoui W, Tierney C, Chung S, Mutlu L, Lu L, Azodi M, Ratner E, Menderes G
Int J Gynaecol Obstet 2020 Sep;150(3):385-391. Epub 2020 Jun 26 doi: 10.1002/ijgo.13254. PMID: 32506422
A universal genetic testing initiative for patients with high-grade, non-mucinous epithelial ovarian cancer and the implications for cancer treatment.
Bednar EM, Oakley HD, Sun CC, Burke CC, Munsell MF, Westin SN, Lu KH
Gynecol Oncol 2017 Aug;146(2):399-404. Epub 2017 Jun 10 doi: 10.1016/j.ygyno.2017.05.037. PMID: 28610746Free PMC Article
The combination of gemcitabine and carboplatin shows similar efficacy in the treatment of platinum-resistant and platinum-sensitive recurrent epithelial ovarian cancer patients.
Safra T, Asna N, Veizman A, Shpigel S, Matcejevsky D, Inbar M, Grisaru D
Anticancer Drugs 2014 Mar;25(3):340-5. doi: 10.1097/CAD.0000000000000042. PMID: 24185383

Recent clinical studies

Etiology

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.
Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Banerjee S, García-Donas J, Swisher EM, Cameron T, Maloney L, Goble S, Coleman RL
Lancet Oncol 2020 May;21(5):710-722. doi: 10.1016/S1470-2045(20)30061-9. PMID: 32359490Free PMC Article
Long-Term Survival After Surgery and Radiotherapy for Recurrent or Persistent Ovarian and Tubal Cancer.
Rome R, Dipnall J, Leung S
Int J Gynecol Cancer 2018 Jul;28(6):1090-1100. doi: 10.1097/IGC.0000000000001294. PMID: 29846300
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA; ARIEL3 investigators
Lancet 2017 Oct 28;390(10106):1949-1961. Epub 2017 Sep 12 doi: 10.1016/S0140-6736(17)32440-6. PMID: 28916367Free PMC Article
Laparoscopy versus laparotomy for the management of early stage endometrial cancer.
Galaal K, Bryant A, Fisher AD, Al-Khaduri M, Kew F, Lopes AD
Cochrane Database Syst Rev 2012 Sep 12;(9):CD006655. doi: 10.1002/14651858.CD006655.pub2. PMID: 22972096
Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study.
Rabczyński J, Ziółkowski P
Pathol Oncol Res 1999;5(1):61-6. doi: 10.1053/paor.1999.0061. PMID: 10079381

Diagnosis

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.
Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Banerjee S, García-Donas J, Swisher EM, Cameron T, Maloney L, Goble S, Coleman RL
Lancet Oncol 2020 May;21(5):710-722. doi: 10.1016/S1470-2045(20)30061-9. PMID: 32359490Free PMC Article
Uterine endosalpingiosis: Case report and review of the literature.
Yang M, Li Y, Chen M, Chen J, Kung FT
Taiwan J Obstet Gynecol 2019 May;58(3):324-327. doi: 10.1016/j.tjog.2019.03.006. PMID: 31122517
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA; ARIEL3 investigators
Lancet 2017 Oct 28;390(10106):1949-1961. Epub 2017 Sep 12 doi: 10.1016/S0140-6736(17)32440-6. PMID: 28916367Free PMC Article
Skin metastases in epithelial ovarian and fallopian tube carcinoma.
Otsuka I, Matsuura T
Medicine (Baltimore) 2017 Aug;96(33):e7798. doi: 10.1097/MD.0000000000007798. PMID: 28816970Free PMC Article
Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study.
Rabczyński J, Ziółkowski P
Pathol Oncol Res 1999;5(1):61-6. doi: 10.1053/paor.1999.0061. PMID: 10079381

Therapy

Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer.
Backes FJ, Wei L, Chen M, Hill K, Dzwigalski K, Poi M, Phelps M, Salani R, Copeland LJ, Fowler JM, Cohn DE, Bixel K, Cosgrove C, Hays J, O'Malley D
Gynecol Oncol 2021 Sep;162(3):619-625. Epub 2021 Jul 14 doi: 10.1016/j.ygyno.2021.06.032. PMID: 34272090
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.
Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Banerjee S, García-Donas J, Swisher EM, Cameron T, Maloney L, Goble S, Coleman RL
Lancet Oncol 2020 May;21(5):710-722. doi: 10.1016/S1470-2045(20)30061-9. PMID: 32359490Free PMC Article
The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy.
Nakamura M, Obata T, Daikoku T, Fujiwara H
Int J Mol Sci 2019 Nov 4;20(21) doi: 10.3390/ijms20215482. PMID: 31689961Free PMC Article
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA; ARIEL3 investigators
Lancet 2017 Oct 28;390(10106):1949-1961. Epub 2017 Sep 12 doi: 10.1016/S0140-6736(17)32440-6. PMID: 28916367Free PMC Article
Laparoscopy versus laparotomy for the management of early stage endometrial cancer.
Galaal K, Bryant A, Fisher AD, Al-Khaduri M, Kew F, Lopes AD
Cochrane Database Syst Rev 2012 Sep 12;(9):CD006655. doi: 10.1002/14651858.CD006655.pub2. PMID: 22972096

Prognosis

The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy.
Nakamura M, Obata T, Daikoku T, Fujiwara H
Int J Mol Sci 2019 Nov 4;20(21) doi: 10.3390/ijms20215482. PMID: 31689961Free PMC Article
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA; ARIEL3 investigators
Lancet 2017 Oct 28;390(10106):1949-1961. Epub 2017 Sep 12 doi: 10.1016/S0140-6736(17)32440-6. PMID: 28916367Free PMC Article
Skin metastases in epithelial ovarian and fallopian tube carcinoma.
Otsuka I, Matsuura T
Medicine (Baltimore) 2017 Aug;96(33):e7798. doi: 10.1097/MD.0000000000007798. PMID: 28816970Free PMC Article
Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study.
Rabczyński J, Ziółkowski P
Pathol Oncol Res 1999;5(1):61-6. doi: 10.1053/paor.1999.0061. PMID: 10079381
Endometrioid carcinoma of the fallopian tube: a clinicopathologic analysis of 26 cases.
Navani SS, Alvarado-Cabrero I, Young RH, Scully RE
Gynecol Oncol 1996 Dec;63(3):371-8. doi: 10.1006/gyno.1996.0338. PMID: 8946874

Clinical prediction guides

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M, Thaker PH, Wahner-Hendrickson AE, Aghajanian C
Gynecol Oncol 2023 Sep;176:16-24. Epub 2023 Jul 5 doi: 10.1016/j.ygyno.2023.06.021. PMID: 37418832Free PMC Article
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer.
Backes FJ, Wei L, Chen M, Hill K, Dzwigalski K, Poi M, Phelps M, Salani R, Copeland LJ, Fowler JM, Cohn DE, Bixel K, Cosgrove C, Hays J, O'Malley D
Gynecol Oncol 2021 Sep;162(3):619-625. Epub 2021 Jul 14 doi: 10.1016/j.ygyno.2021.06.032. PMID: 34272090
The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy.
Nakamura M, Obata T, Daikoku T, Fujiwara H
Int J Mol Sci 2019 Nov 4;20(21) doi: 10.3390/ijms20215482. PMID: 31689961Free PMC Article
Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?
Amit A, Sabo E, Movsas A, Efrat-Tamam Y, Reiss A, Matanes E, Klorin G
PLoS One 2019;14(2):e0211329. Epub 2019 Feb 28 doi: 10.1371/journal.pone.0211329. PMID: 30818325Free PMC Article
Primary endometrioid carcinoma of fallopian tube. Clinicomorphologic study.
Rabczyński J, Ziółkowski P
Pathol Oncol Res 1999;5(1):61-6. doi: 10.1053/paor.1999.0061. PMID: 10079381

Recent systematic reviews

Laparoscopy versus laparotomy for the management of early stage endometrial cancer.
Galaal K, Donkers H, Bryant A, Lopes AD
Cochrane Database Syst Rev 2018 Oct 31;10(10):CD006655. doi: 10.1002/14651858.CD006655.pub3. PMID: 30379327Free PMC Article
Laparoscopy versus laparotomy for the management of early stage endometrial cancer.
Galaal K, Bryant A, Fisher AD, Al-Khaduri M, Kew F, Lopes AD
Cochrane Database Syst Rev 2012 Sep 12;(9):CD006655. doi: 10.1002/14651858.CD006655.pub2. PMID: 22972096

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...